The Latest Breaking News from diabetes

Nicole hit the headlines recently after getting engaged to partner Ryan at the Ed Sheeran concert in Belfast

Erectile Dysfunction can become an increasing problem as men get older. While this issue is a normal part of the ageing process, new research shows that it is also a key predictor of early mortality.

The FDA approved Eli Lilly And Co's (NYSE:LLY) injected drug tirzepatide, which has the brand name Mounjaro (tirzepatide), to help improve blood sugar control in adults with type 2 diabetes. The approval covers tirzepatide as an adjunct to diet and exercise. As the first and only FDA-approved GIP (glucose-dependent insulinotropic polypeptide) and GLP-1…

Problems with your mouth, teeth and gums are usually a dental issue – but occasionally they could also be giving a warning you shouldn’t ignore, says Natasha Holt

Arkansas has accused Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Sanofi SA (NASDAQ:SNY), and three of the largest pharmacy benefit managers (PBMs) of artificially driving up insulin prices. The complaint, filed by Arkansas Attorney General Leslie Rutledge, alleges the defendants devised a scheme in which the Big Pharmas would "artificially and willingly raise their…

With the number of people living with diabetes expected to rise, Gateshead's clinical commissioning group is set to help people at risk

Becton Dickinson and Co's (NYSE:BDX) pure-play diabetes spin-off Embecta Corp (NASDAQ:EMBC) has reported Q2 sales of $274.5 million, down 3.4% on a reported basis, down 1.3% on a constant currency basis. Of the decrease, $6.0 million was attributable to unfavorable effects from foreign currency translation.  Volume unfavorably impacted revenues by approximately $3.7 million, primarily…

Indians are especially at risk of Type 2 Diabetes because they are centrally obese

Eli Lilly is the IBD Stock Of The Day after "transformative" data in obesity helped LLY stock retain its recent breakout.